Logo image of NUMI.CA

NUMINUS WELLNESS INC (NUMI.CA) Stock Price, Quote, News and Overview

TSX:NUMI - Toronto Stock Exchange - CA67054W1032 - Common Stock - Currency: CAD

0.05  +0.02 (+42.86%)

NUMI.CA Quote, Performance and Key Statistics

NUMINUS WELLNESS INC

TSX:NUMI (1/29/2025, 7:00:00 PM)

0.05

+0.02 (+42.86%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High0.13
52 Week Low0.03
Market Cap16.12M
Shares322.32M
Float309.90M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO08-10 1982-08-10


NUMI.CA short term performance overview.The bars show the price performance of NUMI.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60

NUMI.CA long term performance overview.The bars show the price performance of NUMI.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of NUMI.CA is 0.05 CAD. In the past month the price increased by 25%. In the past year, price decreased by -58.33%.

NUMINUS WELLNESS INC / NUMI Daily stock chart

NUMI.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
WEED-DB.CA CANOPY GROWTH CORP N/A 9.54B
BHC.CA BAUSCH HEALTH COS INC 1.41 2.71B
CRON.CA CRONOS GROUP INC 18.5 998.21M
TLRY.CA TILRAY BRANDS INC N/A 684.42M
DHT-UN.CA DRI HEALTHCARE TRUST 5.3 647.57M
GUD.CA KNIGHT THERAPEUTICS INC 121.6 604.66M
WEED.CA CANOPY GROWTH CORP N/A 399.25M
ACB.CA AURORA CANNABIS INC 27.83 351.10M
CPH.CA CIPHER PHARMACEUTICALS INC 21.13 346.38M
HITI.CA HIGH TIDE INC N/A 268.72M
TSND.CA TERRASCEND CORP N/A 220.81M
OGI.CA ORGANIGRAM GLOBAL INC N/A 216.72M

About NUMI.CA

Company Profile

NUMI logo image Numinus Wellness, Inc. engages in the development of psychedelic-centered therapeutic products. The company is headquartered in Montreal, Quebec. The firm focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training segment is engaged in education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network segment includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. Corporate segment includes finance, marketing, information technology, legal, and human resources.

Company Info

NUMINUS WELLNESS INC

393 Laurier Ave W

MONTREAL QUEBEC V6B 1R4 CA

CEO: Payton Nyquvest

Employees: 0

Company Website: https://numinus.com/

Investor Relations: http://www.investors.numinus.com/overview/default.aspx

Phone: 18336864687.0

NUMINUS WELLNESS INC / NUMI.CA FAQ

What is the stock price of NUMINUS WELLNESS INC today?

The current stock price of NUMI.CA is 0.05 CAD. The price increased by 42.86% in the last trading session.


What is the ticker symbol for NUMINUS WELLNESS INC stock?

The exchange symbol of NUMINUS WELLNESS INC is NUMI and it is listed on the Toronto Stock Exchange exchange.


On which exchange is NUMI.CA stock listed?

NUMI.CA stock is listed on the Toronto Stock Exchange exchange.


What is NUMINUS WELLNESS INC worth?

NUMINUS WELLNESS INC (NUMI.CA) has a market capitalization of 16.12M CAD. This makes NUMI.CA a Nano Cap stock.


How many employees does NUMINUS WELLNESS INC have?

NUMINUS WELLNESS INC (NUMI.CA) currently has 0 employees.


What are the support and resistance levels for NUMINUS WELLNESS INC (NUMI.CA) stock?

NUMINUS WELLNESS INC (NUMI.CA) has a support level at 0.05. Check the full technical report for a detailed analysis of NUMI.CA support and resistance levels.


Is NUMINUS WELLNESS INC (NUMI.CA) expected to grow?

The Revenue of NUMINUS WELLNESS INC (NUMI.CA) is expected to decline by -18.04% in the next year. Check the estimates tab for more information on the NUMI.CA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NUMINUS WELLNESS INC (NUMI.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NUMINUS WELLNESS INC (NUMI.CA) stock pay dividends?

NUMI.CA does not pay a dividend.


What is the Price/Earnings (PE) ratio of NUMINUS WELLNESS INC (NUMI.CA)?

NUMINUS WELLNESS INC (NUMI.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.11).


NUMI.CA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to NUMI.CA. When comparing the yearly performance of all stocks, NUMI.CA turns out to be only a medium performer in the overall market: it outperformed 45.79% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NUMI.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NUMI.CA. NUMI.CA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NUMI.CA Financial Highlights

Over the last trailing twelve months NUMI.CA reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS increased by 37.67% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -213.24%
ROE -644.74%
Debt/Equity 0.95
Chartmill High Growth Momentum
EPS Q2Q%35.87%
Sales Q2Q%-27.88%
EPS 1Y (TTM)37.67%
Revenue 1Y (TTM)22.69%

NUMI.CA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to NUMI.CA. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 58.33% and a revenue growth -18.04% for NUMI.CA


Ownership
Inst Owners2.66%
Ins Owners3.55%
Short Float %N/A
Short RatioN/A
Analysts
Analysts82.86
Price TargetN/A
EPS Next Y58.33%
Revenue Next Year-18.04%